(Q39186650)

9 September 2017

HIV-1 Vpr activates both canonical and noncanonical NF-κB pathway by enhancing the phosphorylation of IKKα/β. (English)

1 reference

9 September 2017

0 references

1 reference

Ruikang Liu

1

1 reference

9 September 2017

Juan Tan

2

1 reference

9 September 2017

Yongquan Lin

3

1 reference

9 September 2017

Rui Jia

4

1 reference

9 September 2017

Wei Yang

5

1 reference

9 September 2017

Chen Liang

6

1 reference

9 September 2017

Yunqi Geng

7

1 reference

9 September 2017

Wentao Qiao

8

1 reference

9 September 2017

language of work or name

English

0 references

publication date

28 February 2013

1 reference

9 September 2017

1 reference

9 September 2017

439

1 reference

9 September 2017

1

1 reference

9 September 2017

47-56

1 reference

Phosphorylation of Vpr regulates HIV type 1 nuclear import and macrophage infection

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Mechanism of processing of the NF-kappa B2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCF(beta-TrCP) ubiquitin ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

NF-kappaB cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Protein kinase A phosphorylation activates Vpr-induced cell cycle arrest during human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

HIV gp120 induces, NF-kappaB dependent, HIV replication that requires procaspase 8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Herpes virus proteins ICP0 and BICP0 can activate NF-kappaB by catalyzing IkappaBalpha ubiquitination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Emerging concepts in the immunopathogenesis of AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Determinants of the establishment of human immunodeficiency virus type 1 latency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappaB, and AP-1 induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Regulation and function of IKK and IKK-related kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

7 January 2021

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

HIV-1 Vpr induces TLR4/MyD88-mediated IL-6 production and reactivates viral production from latency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Nuclear localization of Vpr is crucial for the efficient replication of HIV-1 in primary CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Activation of the I kappa B alpha kinase (IKK) complex by double-stranded RNA-binding defective and catalytic inactive mutants of the interferon-inducible protein kinase PKR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Dynamics of HIV-1 recombination in its natural target cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

beta-TrCP binding and processing of NF-kappaB2/p100 involve its phosphorylation at serines 866 and 870.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Activation of the noncanonical NF-κB pathway by HIV controls a dendritic cell immunoregulatory phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

NF-kappaB: the inducible factors of HIV-1 transcription and their inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

The cytoplasmic domain of the HIV-1 glycoprotein gp41 induces NF-κB activation through TGF-β-activated kinase 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Non-canonical NF-κB signaling activation and regulation: principles and perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

NF-kappaB and virus infection: who controls whom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

The role of ubiquitin in NF-kappaB regulatory pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Non-canonical NF-κB signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

IFP35 is involved in the antiviral function of interferon by association with the viral tas transactivator of bovine foamy virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Evolution of the primate lentiviruses: evidence from vpx and vpr

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Complex Evolutionary History of Primate LentiviralvprGenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-kappaB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Bovine foamy virus transactivator BTas interacts with cellular RelB to enhance viral transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

BFV activates the NF-kappaB pathway through its transactivator (BTas) to enhance viral transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Interaction of Virion Protein Vpr of Human Immunodeficiency Virus Type 1 with Cellular Transcription Factor Sp1 and trans-Activation of Viral Long Terminal Repeat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Phosphorylation of human immunodeficiency virus type 1 Vpr regulates cell cycle arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

inferred from DOI database lookup

7 January 2021

based on heuristic

Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

inferred from DOI database lookup

7 January 2021

based on heuristic

Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.01.020

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2013.01.020

1 reference

9 September 2017

1 reference